ThermaSolutions at PSOGI 2025 At this year’s PSOGI Congress in Barcelona, ThermaSolutions will showcase its pioneering role in advancing intraperitoneal cancer therapy through HIPEC (Hyperthermic Intraperitoneal Chemotherapy) and PIPAC (Pressurized Intraperitoneal Aerosol Chemotherapy) technologies.
As a global leader, ThermaSolutions continues to set the benchmark for safety, reliability, and performance in treating peritoneal surface malignancies. With its ThermoChem™ systems, the company empowers clinicians worldwide to deliver precise, temperature-controlled chemotherapy with confidence and consistency.
Driven by innovation and a commitment to improving patient outcomes, ThermaSolutions remains at the forefront of the fight against peritoneal metastases — shaping the future of intraperitoneal therapy.
Meet ThermaSolutions at PSOGI 2025
October 29–31 | Stand 3